134 related articles for article (PubMed ID: 32164951)
21. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
22. Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways.
Luan Y; Liu J; Liu X; Xue X; Kong F; Sun C; Wang J; Liu L; Jia H
Int J Oncol; 2016 Oct; 49(4):1704-12. PubMed ID: 27633040
[TBL] [Abstract][Full Text] [Related]
23. Esculetin inhibits the proliferation of human lung cancer cells by targeting epithelial-to-mesenchymal transition of the cells.
Li H; Wang Q; Wang Y; Xu Z; Han Z
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):95-98. PubMed ID: 31880524
[TBL] [Abstract][Full Text] [Related]
24. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells.
Kimura Y; Sumiyoshi M
Eur J Pharmacol; 2015 Jan; 746():115-25. PubMed ID: 25445053
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells.
Lee SJ; Lee US; Kim WJ; Moon SK
Mol Med Rep; 2011; 4(2):337-41. PubMed ID: 21468574
[TBL] [Abstract][Full Text] [Related]
26. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-Regulated miR-146a Targets Cell Adhesion Molecule 2 to Promote Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Yang L; Zhao G; Wang F; Li C; Wang X
Cell Physiol Biochem; 2018; 49(3):920-931. PubMed ID: 30184528
[TBL] [Abstract][Full Text] [Related]
28. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
[TBL] [Abstract][Full Text] [Related]
29. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
30.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
31. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
32. Effect of EH domain containing protein 2 on the biological behavior of clear cell renal cell carcinoma.
Liu C; Liu S; Wang L; Wang Y; Li Y; Cui Y
Hum Exp Toxicol; 2019 Aug; 38(8):927-937. PubMed ID: 30995867
[TBL] [Abstract][Full Text] [Related]
33. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin.
Wang CJ; Hsieh YJ; Chu CY; Lin YL; Tseng TH
Cancer Lett; 2002 Sep; 183(2):163-8. PubMed ID: 12065091
[TBL] [Abstract][Full Text] [Related]
35. Esculetin induces cell cycle arrest and apoptosis in human colon cancer LoVo cells.
Choi YJ; Lee CM; Park SH; Nam MJ
Environ Toxicol; 2019 Oct; 34(10):1129-1136. PubMed ID: 31313495
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity.
Jiménez-Orozco FA; Rosales AA; Vega-López A; Domínguez-López ML; García-Mondragón MJ; Maldonado-Espinoza A; Lemini C; Mendoza-Patiño N; Mandoki JJ
Eur J Pharmacol; 2011 Oct; 668(1-2):35-41. PubMed ID: 21741969
[TBL] [Abstract][Full Text] [Related]
37. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro.
Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
[TBL] [Abstract][Full Text] [Related]
38. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
39. Antiovarian cancer mechanism of esculetin: inducing G0/G1 arrest and apoptosis via JAK2/STAT3 signalling pathway.
Yin W; Fu X; Chang W; Han L; Meng J; Cao A; Ren X; Fan Z; Zhou S
J Pharm Pharmacol; 2023 Jan; 75(1):87-97. PubMed ID: 36332079
[TBL] [Abstract][Full Text] [Related]
40. Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells.
Lee SH; Park C; Jin CY; Kim GY; Moon SK; Hyun JW; Lee WH; Choi BT; Kwon TK; Yoo YH; Choi YH
Biomed Pharmacother; 2008 Dec; 62(10):723-9. PubMed ID: 18222060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
